(1) Background: In order to avoid a liver biopsy in non-alcoholic fatty liver disease (NAFLD),
several noninvasive biomarkers have been studied lately. Therefore, we aimed to evaluate …

BACKGROUND & AIMS: Visceral adiposity is associated with hepatic steatosis,
inflammation, and fibrosis in non-alcoholic fatty liver disease (NAFLD). The visceral …

Abstract Background & Aims Although evidence indicates that visceral adipose tissue is
associated with nonalcoholic fatty liver disease (NAFLD), it is unclear whether the visceral …

Abstract Background and Aim Many abdominal obesity indices such as waist circumference
(WC), lipid accumulation product (LAP), visceral obesity index (VAI), and Chinese VAI …

Aliment Pharmacol Ther 2012; 35: 238–247 Summary Background Metabolic factors have
been associated with liver damage in patients with non‐alcoholic fatty liver disease …

Background and aims: Visceral adiposity index (VAI), calculated with body mass index, high-
density lipoprotein cholesterol, triglyceride and waist circumference, has been proposed as …

The objective was to critically analyze studies that evaluated the predictive capacity of
indicators of visceral adiposity in non-alcoholic fatty liver disease (NAFLD). The …

Backgrounds Non-obese nonalcoholic fatty liver disease (NAFLD) is paradoxically
associated with improved metabolic and pathological features at diagnosis but worse …

Background Chinese visceral adiposity index (CVAI) is a novel indicator that precisely
evaluates visceral obesity and has been shown to be significantly associated with …

Introduction Nonalcoholic fatty liver disease (NAFLD) is the liver manifestation of
adiposopathy. Recently, a new score was developed to estimate body fat percentage …